Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8721527 | 0.86 | — | — | |
| SCHEMBL7127257 | 0.77 | GAA (0.35) | GAA | |
| SCHEMBL25966308 | 0.75 | ALDH1A1 (0.33) | GAA | |
| SCHEMBL5313149 | 0.75 | POLB (0.32) | — | |
| SCHEMBL455104 | 0.72 | KDM4E (0.36) | GAA | |
| SCHEMBL1477727 | 0.72 | KDM4E (0.42) | GAA | |
| SCHEMBL8475877 | 0.70 | KDM4E (0.46) | — | |
| SCHEMBL26452808 | 0.69 | PAOX (0.37) | GAA | |
| SCHEMBL24779728 | 0.67 | EPHX1 (0.41) | — | |
| SCHEMBL14561907 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3177326-A1 | SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS | The Ohio State Innovation Foundation (US) | 2017-06-14 | — | — | EP | claimed |
| WO-2016022987-A1 | SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS | OHIO STATE INNOVATION FOUNDATION (US) | 2016-02-11 | — | — | WO | claimed |
| US-20140363378-A1 | SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS | THE OHIO STATE UNIVERSITY | 2014-12-11 | — | — | US | claimed |
| WO-2013116645-A1 | SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS | THE OHIO STATE UNIVERSITY (US) | 2013-08-08 | — | — | WO | claimed |
| EP-0629617-B2 | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INT BV (NL) | 2007-09-26 | — | — | EP | claimed |
| CN-1055685-C | Heteroatom-bearing ligands and metal complexes thereof | BRAKER INTERNAT B V (NL) | 2000-08-23 | — | — | CN | claimed |
| EP-0629617-B1 | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INT BV (NL) | 1998-04-29 | — | — | EP | claimed |
| US-5665329-A | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INTERNATIONAL B.V. | 1997-09-09 | — | — | US | claimed |
| CN-1099388-A | Heteroatom-bearing ligands and metal complexes thereof | BRISTOL MYERS SQIBB COMPANY (US) | 1995-03-01 | — | — | CN | claimed |
| EP-0629617-A1 | Heteroatom-bearing ligands and metal complexes thereof | BRACCO International B.V. (NL) | 1994-12-21 | — | — | EP | claimed |
| CN-111225679-B | Novel peptide-based cancer imaging agents | 俄亥俄州创新基金会 | 2024-03-29 | — | — | CN | disclosed |
| US-20230338584-A1 | NOVEL PEPTIDE-BASED CANCER IMAGING AGENTS | OHIO STATE INNOVATION FOUNDATION | 2023-10-26 | — | — | US | disclosed |
| US-20220218834-A1 | APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-07-14 | — | — | US | disclosed |
| US-11358982-B2 | Methods for the iodination of biomolecules | OHIO STATE INNOVATION FOUNDATION (US) | 2022-06-14 | — | — | US | disclosed |
| WO-2020236952-A1 | APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2020-11-26 | — | — | WO | disclosed |
| US-5656254-A | Polyaza heteroatom-bearing ligands and metal complexes thereof for imaging or radiotherapy | BRACCO INTERNATIONAL B.V. | 1997-08-12 | — | — | US | disclosed |
| US-5627286-A | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INTERNATIONAL B.V. | 1997-05-06 | — | — | US | disclosed |
| US-5608110-A | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INTERNATIONAL B.V. | 1997-03-04 | — | — | US | disclosed |
| CN-1099388-A | Heteroatom-bearing ligands and metal complexes thereof | BRISTOL MYERS SQIBB COMPANY (US) | 1995-03-01 | — | — | CN | disclosed |
| EP-0629617-A1 | Heteroatom-bearing ligands and metal complexes thereof | BRACCO International B.V. (NL) | 1994-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140363378-A1 | SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS | TP53, EGFR, HIF1A | GAA 1018/4885 |
| US-11358982-B2 | Methods for the iodination of biomolecules | TPO, LPO, MPO | GAA 1752/4885 |
| US-20220218834-A1 | APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF | HBG1, HBG2, LPO | GAA 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.